Prostate Cancer Surgery
Prostate Cancer Treatment
Prostate cancer treatment involves a range of clinical interventions aimed at managing or eliminating malignant cells within the prostate gland. Modern treatment focuses on high-precision oncology, utilizing robotic surgery and targeted radioligand therapies to address tumors while preserving urinary and reproductive function. This ensures a personalized approach based on the specific aggressiveness of the disease.
When You Should Consider Screening
Increased Urinary Frequency: Particularly noticing the need to urinate more often during the night (nocturia).
Weak or Interrupted Flow: Noticing a hesitant, weak, or frequently interrupted urine stream.
Difficulty Starting: Struggling to start or maintain a consistent stream of urination.
Hematuria or Hematospermia: The presence of blood in the urine or the seminal fluid.
Discomfort: Persistent pain or a burning sensation during urination or ejaculation.
Chronic Pain: Persistent discomfort in the lower back, hips, or pelvic region that does not resolve with rest.
Conditions That Require Specialized Care
Adenocarcinoma: Confirmed prostate cancer often initially identified through elevated PSA (Prostate-Specific Antigen) levels.
High-Risk Tumors: Aggressive disease characterized by a high Gleason score (8–10).
Metastatic Disease: Cancer that has migrated beyond the gland to the bones or pelvic lymph nodes.
Recurrent Cancer: Cases where PSA levels begin to rise following initial surgical or radiation interventions.
Genetic Predispositions: Patients with inherited mutations such as BRCA1, BRCA2, or HOXB13, which may require specialized precision therapies.
How It Is Performed
Mapping: Multiparametric MRI (mpMRI) is utilized to visualize and map suspicious areas within the gland with high anatomical detail.
Biopsy: A targeted biopsy is conducted to confirm the presence of malignant cells and determine the precise grade of the tumor.
Robotic Surgery: A robotic-assisted radical prostatectomy is performed to remove the prostate gland with sub-millimeter precision, protecting adjacent nerves.
Hormonal Control: Androgen Deprivation Therapy (ADT) is administered via medication to reduce the testosterone levels fueling the cancer's growth.
Radioligand Therapy: Advanced systemic agents are introduced to the bloodstream to deliver radiation directly to cells expressing specific proteins like PSMA.
Monitoring: Regular follow-up testing of PSA levels is conducted to monitor the success of the treatment and ensure continued remission.
Types of Prostate Cancer Treatment
Robotic-Assisted Radical Prostatectomy: A minimally invasive surgical procedure to remove the entire prostate gland and nearby tissues through small incisions.
Active Surveillance: An intensive monitoring protocol for low-risk, slow-growing tumors designed to safely delay or avoid invasive intervention.
Stereotactic Body Radiation Therapy (SBRT): A highly targeted radiation treatment that delivers concentrated, high-dose beams to the tumor site while sparing healthy tissue.
Targeted Radioligand Therapy: An advanced treatment that seeks out and destroys cancer cells throughout the body by targeting the PSMA protein.
PARP Inhibitors: Precision medications used for patients with specific genetic mutations to block cancer cells from repairing their DNA.
Hormone Therapy (ADT): Systemic medications designed to "starve" cancer cells of the hormones they need to grow and spread.
Pre-Surgery Preparation
Functional Consultation: Discuss potential impacts on urinary and sexual function with the surgical oncology team to set clear expectations.
Pelvic Floor Strength: Engage in pelvic floor exercises (Kegels) to strengthen the muscles responsible for continence before the procedure.
Clinical Guidelines: Adhere to strict fasting and medication instructions provided by the medical team.
Cardiovascular Assessment: Undergo a heart health evaluation to ensure readiness for a robotic surgical approach.
Recovery Planning: Arrange for a post-operative period that includes assistance with daily tasks during the initial phase of healing.
Tests Before Prostate Cancer Treatment
PSA Blood Test: To measure the current biochemical activity of the prostate gland.
Multiparametric MRI (mpMRI): To provide a detailed "roadmap" for the surgical or radiation oncology team.
Genomic Profiling: Testing the biopsy tissue to determine the exact Gleason score and the presence of specific genetic mutations.
PSMA PET/CT or Bone Scan: Advanced imaging to confirm whether the cancer is localized to the pelvis or has spread to the bones.
Comprehensive Blood Panels: A routine check of your blood count, electrolytes, and kidney function before the administration of anesthesia.
Life After Prostate Cancer Treatment
PSA Surveillance: Regular blood tests every few months to ensure PSA levels remain at undetectable or baseline levels.
Metabolic Health: Adoption of a heart-healthy diet and consistent exercise to support overall health and mitigate potential side effects of therapy.
Hormonal Management: Ongoing consultation with specialists to manage bone density, energy levels, and metabolic health.
Follow-up Imaging: Commitment to long-term diagnostic check-ups and scans as scheduled by your oncology team.
Wellness Support: Participation in survivor networks to navigate lifestyle changes and emotional health following treatment.
Why Specialized Treatment Is Highly Effective
High Survival Rates: Localized prostate cancer boasts a nearly 100% five-year survival rate through early detection and modern intervention.
Radioligand Technology: Utilizes systemic radiation to treat advanced stages with significantly fewer side effects than traditional chemotherapy.
Nerve-Sparing Robotics: Employs advanced robotic systems that protect the vital nerve bundles responsible for urinary continence and sexual potency.
Genetic Personalization: Offers maintenance plans that target the specific genetic signature of your tumor for more durable results.
Combined Systemic Therapies: Significantly improves outcomes for metastatic patients through protocols that combine hormone, radiation, and targeted therapies.